title: Tetraspanin CD151 Promotes Initial Events in Human Cytomegalovirus Infection.
abstract: Human cytomegalovirus (HCMV), a betaherpesvirus, can cause life-threatening disease in immunocompromised individuals. Viral envelope glycoproteins that mediate binding to and penetration into target cells have been identified previously. In contrast, cellular proteins supporting HCMV during entry are largely unknown. In order to systematically identify host genes affecting initial steps of HCMV infection, a targeted RNA interference screen of 96 cellular genes was performed in endothelial cells by use of a virus strain expressing the full set of known glycoprotein H and L (gH/gL) complexes. The approach yielded five proviral host factors from different protein families and eight antiviral host factors, mostly growth factor receptors. The tetraspanin CD151 was uncovered as a novel proviral host factor and was analyzed further. Like endothelial cells, fibroblasts were also less susceptible to HCMV infection after CD151 depletion. Virus strains with different sets of gH/gL complexes conferring either broad or narrow cell tropism were equally impaired. Infection of CD151-depleted cells by a fluorescent virus with differentially labeled capsid and envelope proteins revealed a role of CD151 in viral penetration but not in adsorption to the cell. In conclusion, the tetraspanin CD151 has emerged as a novel host factor in HCMV entry and as a putative antiviral target.
  
  
  
  At present, the events at the virus-cell interface and the cellular proteins involved during the HCMV entry steps are scarcely understood. In this study, several host factors with putative roles in this process were identified. The tetraspanin CD151 was discovered as a previously unrecognized proviral host factor for HCMV and was found to support viral penetration into the target cells. The findings of this study shed light on the cellular contribution during the initial steps of HCMV infection and open a new direction in HCMV research.
authors.affiliation: Institute of Virology, Ulm University Medical Center, Ulm, Germany.
authors.forename: Daniel
authors.initials: D
authors.lastname: Hochdorfer
authors.affiliation: Department of Medical Microbiology and Hygiene, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
authors.forename: Luise
authors.initials: L
authors.lastname: Florin
authors.affiliation: Institute of Virology, Ulm University Medical Center, Ulm, Germany.
authors.forename: Christian
authors.initials: C
authors.lastname: Sinzger
authors.affiliation: Institute of Virology, Ulm University Medical Center, Ulm, Germany Diana.Lieber@uni-ulm.de.
authors.forename: Diana
authors.initials: D
authors.lastname: Lieber
mesh_terms: D002478:Cells, Cultured; D003587:Cytomegalovirus; D005347:Fibroblasts / Q000378:metabolism / Q000821:virology*; D017353:Gene Deletion; D061307:Human Umbilical Vein Endothelial Cells / Q000378:metabolism / Q000821:virology*; D006801:Humans; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000235:genetics; D060185:Tetraspanin 24 / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D014759:Viral Envelope Proteins / Q000378:metabolism*; D053586:Virus Internalization
chemical_list: C554715:CD151 protein, human; D034741:RNA, Small Interfering; D060185:Tetraspanin 24; C077406:UL115 protein, Human herpesvirus 5; D014759:Viral Envelope Proteins; C071440:glycoprotein H, Cytomegalovirus